Send us Feedback

Abraxis BioScience (ABII)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ABII » Topics » Contractual Obligations

This excerpt taken from the ABII 10-K filed Mar 12, 2010.

Contractual Obligations

Contractual obligations represent future cash commitments and liabilities under agreements with third parties, and exclude contingent liabilities for which we cannot reasonably predict future payment. Accordingly, the table below excludes contractual obligations relating to milestones and royalty payments due to third parties contingent upon certain future events. Such events could include, but are not limited to, development milestones, regulatory approvals, and product sales. The following information summarizes our contractual obligations and other commitments as of December 31, 2009:

 

     Payments due by period

Contractual Obligations

    Total    Less than
1 year		    1-3 years    3-5 years    More than
5 years
     (in thousands)

Unconditional purchase obligations

    $ 269,565    $ 52,536    $ 85,151    $ 65,016    $ 66,862

Operating lease obligations

      26,790      10,333      9,087      5,288      2,082

Other long term obligations

      12,054      8,306      3,748      —        —  
                                  

Total contractual cash obligations

    $ 308,409    $ 71,175    $ 97,986    $ 70,304    $ 68,944
                                  
This excerpt taken from the ABII 10-K filed Mar 6, 2009.

Contractual Obligations

Contractual obligations represent future cash commitments and liabilities under agreements with third parties, and exclude contingent liabilities for which we cannot reasonably predict future payment. Accordingly, the table below excludes contractual obligations relating to milestones and royalty payments due to third parties contingent upon certain future events. Such events could include, but are not limited to, development milestones, regulatory approvals, and product sales. The following information summarizes our contractual obligations and other commitments as of December 31, 2008:

 

     Payments due by period

Contractual Obligations

    Total    Less than
1 year		    1-3 years    3-5 years    More than
5 years
     (in thousands)

Unconditional purchase obligations

    $ 221,288    $ 19,733    $ 85,534    $ 85,584    $ 30,437

Operating lease obligations

      23,307      6,644      13,459      2,914      290

Reacquisition payable

      268,000      268,000      —        —        —  

Other long term obligations

      19,789      4,270      15,519      —        —  
                                  

Total contractual cash obligations

    $ 532,384    $ 298,647    $ 114,512    $ 88,498    $ 30,727
                                  
This excerpt taken from the ABII 10-K filed Mar 31, 2008.

Contractual Obligations

Contractual obligations represent future cash commitments and liabilities under agreements with third parties, and exclude contingent liabilities for which we cannot reasonably predict future payment. Accordingly, the table below excludes contractual obligations relating to milestones and royalty payments due to third parties contingent upon certain future events. Such events could include, but are not limited to, development milestones, regulatory approvals, and product sales. The following information summarizes our contractual obligations and other commitments as of December 31, 2007:

 

      Payments due by period

Contractual Obligations

    Total    Less than
1 year		    1-3 years    3-5 years    More than
5 years
     (in thousands)

Purchase obligations and other commitments

    $ 5,639    $ 3,677    $ 412    $ 400    $ 1,150

Operating lease obligations

      25,231      6,420      10,004      5,775      3,032
                                  

Total

    $ 30,870    $ 10,097    $ 10,416    $ 6,175    $ 4,182
                                  

EXCERPTS ON THIS PAGE:

10-K
Mar 12, 2010
10-K
Mar 6, 2009
10-K
Mar 31, 2008

RELATED TOPICS for ABII:

"Contractual Obligations" elsewhere:

Genzyme (GENZ)
Adherex Technologies (ADH)
Anesiva (ANSV)
Artes Medical (ARTE)
Advancis Pharmaceutical (AVNC)
Avalon Pharmaceuticals (AVRX)
BioProgress (BPRG)
Cell Genesys (CEGE)
CollaGenex Pharmaceuticals (CGPI)
Candela (CLZR)
CuraGen (CRGN)
Zalicus Inc. (CRXX)
Cardiac Science (CSCX)
Labopharm (DDSS)
Diversa (DVSA)
PC GROUP, INC. (GAIT)
Fibrocell Science, Inc. (ILE)
Lipid Sciences (LIPD)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki